Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyFri, 05 Jul 2024 21:44:02 +0200Wed, 22 May 2024 12:08:00 +0200Human medicines European public assessment report (EPAR): Krazati, adagrasib, Date of authorisation: 05/01/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/krazatiHuman medicines European public assessment report (EPAR): Krazati, adagrasib, Date of authorisation: 05/01/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/krazatiWed, 22 May 2024 12:08:00 +0200Human medicineKrazati : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6013_en.pdfKrazati : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6013_en.pdfWed, 22 May 2024 11:22:29 +0200Human medicine